Amneal to Report Third Quarter 2026 Results on November 3, 2026
Key Highlights
- ➤Amneal (AMRX) will report third quarter 2026 results November 3 before market open
- ➤Amneal will host an 8:30 a.m. ET audio webcast for its results
- ➤Amneal has approximately 300 complex generic, specialty and biosimilar medicines
BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on Tuesday, November 3, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be available through the Investor Relations section of the Company's website at investors.amneal.com. Individuals may register for the webcast by clicking here. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers here. The access code is 304152835. A replay of the webcast will be available shortly after the call.
Get started
Create a free account to read the full story.